$AMTY
AMERITYRE CORP Stock $amty

$amty Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000118518522001115 Filed on September 19, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue		$1.925M	$6.496M
YoY Change		40.88%	33.56%
Cost Of Revenue		$1.455M	$4.741M
YoY Change		34.21%	32.46%
Gross Profit		$469.5K	$1.755M
YoY Change		66.5%	36.63%
Gross Profit Margin		24.39%	27.01%
Selling, General & Admin		$369.8K	$1.245M
YoY Change		12.98%	14.74%
% of Gross Profit		78.77%	70.98%
Research & Development		$32.49K	$101.8K
YoY Change		29.44%	-0.44%
% of Gross Profit		6.92%	5.8%
Depreciation & Amortization		$55.45K	$230.2K
YoY Change		8.17%	9.24%
% of Gross Profit		11.81%	13.12%
Operating Expenses		$402.3K	$1.347M
YoY Change		14.16%	13.43%
Operating Profit		$67.18K	$407.5K
YoY Change		-195.36%	322.06%
Interest Expense		$470.00	$65.00
YoY Change		11.9%	-96.2%
% of Operating Profit		0.7%	0.02%
Other Income/Expense, Net		$2.020K	$24.44K
YoY Change		-91.29%	-33.42%
Pretax Income		$69.27K	$431.9K
YoY Change		-230.82%	67.18%
Income Tax			$0.00
% Of Pretax Income			0.0%
Net Earnings		$69.27K	$431.9K
YoY Change		-230.82%	67.18%
Net Earnings / Revenue		3.6%	6.65%
Basic Earnings Per Share
Diluted Earnings Per Share		$923.30	$5.833K
COMMON SHARES
Basic Shares Outstanding	75.79M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$805.2K	$805.2K
YoY Change	55.98%	55.98%
Cash & Equivalents	$805.2K
Short-Term Investments
Other Short-Term Assets	$83.22K	$83.22K
YoY Change	-11.92%	-11.92%
Inventory	$853.8K	$853.8K
Prepaid Expenses
Receivables	$685.6K	$685.7K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.428M	$2.428M
YoY Change	21.49%	21.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$249.7K	$635.0K
YoY Change	-61.83%	-2.92%
Goodwill
YoY Change
Intangibles	$58.21K
YoY Change	-23.38%
Long-Term Investments
YoY Change
Other Assets	$255.9K	$197.7K
YoY Change	46.8%	13.4%
Total Long-Term Assets	$890.9K	$890.9K
YoY Change	-1.49%	-1.49%
TOTAL ASSETS
Total Short-Term Assets	$2.428M	$2.428M
Total Long-Term Assets	$890.9K	$890.9K
Total Assets	$3.319M	$3.319M
YoY Change	14.33%	14.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$701.0K	$701.0K
YoY Change	-8.63%	-8.63%
Accrued Expenses	$149.4K	$149.4K
YoY Change	1.22%	1.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.000K	$2.000K
YoY Change	0.0%	0.0%
Total Short-Term Liabilities	$960.7K	$960.7K
YoY Change	1.91%	1.91%
LONG-TERM LIABILITIES
Long-Term Debt	$60.71K	$60.71K
YoY Change	-1.01%	-1.01%
Other Long-Term Liabilities	$151.2K	$151.2K
YoY Change	-49.7%	-49.7%
Total Long-Term Liabilities	$60.71K	$211.9K
YoY Change	-83.23%	-41.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$960.7K	$960.7K
Total Long-Term Liabilities	$60.71K	$211.9K
Total Liabilities	$1.173M	$1.173M
YoY Change	-10.12%	-10.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$60.85M
YoY Change	-0.7%
Common Stock	$75.79K
YoY Change	3.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.146M	$2.146M
YoY Change
Total Liabilities & Shareholders Equity	$3.319M	$3.319M
YoY Change	14.33%	14.33%

Cashflow Statement

Concept	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	$69.27K	$431.9K
YoY Change	-230.82%	67.18%
Depreciation, Depletion And Amortization	$55.45K	$230.2K
YoY Change	8.17%	9.24%
Cash From Operating Activities	$246.1K	$446.9K
YoY Change	-230.39%	-429.7%
INVESTING ACTIVITIES
Capital Expenditures	-$7.930K	$154.6K
YoY Change	116.08%	-1169.27%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$7.930K	-$157.4K
YoY Change	116.08%	988.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-160.0	-$613.00
YoY Change	-20.0%	13.52%
NET CHANGE
Cash From Operating Activities	246.1K	$446.9K
Cash From Investing Activities	-7.930K	-$157.4K
Cash From Financing Activities	-160.0	-$613.00
Net Change In Cash	238.0K	$289.0K
YoY Change	-223.57%	-291.93%
FREE CASH FLOW
Cash From Operating Activities	$246.1K	$446.9K
Capital Expenditures	-$7.930K	$154.6K
Free Cash Flow	$254.0K	$292.3K
YoY Change	-237.26%	-341.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-50053
CY2022	dei	Entity Registrant Name EntityRegistrantName	AMERITYRE CORPORATION
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0535207
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1501 Industrial Road
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Boulder City
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89005
CY2022	dei	City Area Code CityAreaCode	702
CY2022	dei	Local Phone Number LocalPhoneNumber	293-1930
CY2022	dei	Security12b Title Security12bTitle	N/A
CY2022	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	75787868	shares
CY2021Q4	dei	Entity Public Float EntityPublicFloat	2074639	usd
CY2022	dei	Auditor Firm AuditorFirmId	457
CY2022	dei	Auditor Name AuditorName	Haynie & Company
CY2022	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	805157	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	516192	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	685645	usd
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	728315	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	853837	usd
CY2021Q2	us-gaap	Inventory Net InventoryNet	659333	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	83217	usd
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	94483	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	2427856	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	1998323	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	385366	usd
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	544070	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	583611	usd
CY2021Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	583611	usd
CY2022Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3093034	usd
CY2021Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2910018	usd
CY2022Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	76536	usd
CY2021Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	73423	usd
CY2022Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	233528	usd
CY2021Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	233528	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3737040	usd
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3690515	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	249669	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	110065	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	58214	usd
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	75977	usd
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	186650	usd
CY2021Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	163289	usd
CY2022Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	11000	usd
CY2021Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	11000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	255864	usd
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	250266	usd
CY2022Q2	us-gaap	Assets Assets	3318755	usd
CY2021Q2	us-gaap	Assets Assets	2902724	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	701006	usd
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	767193	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000	usd
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	149400	usd
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	147600	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	108313	usd
CY2021Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	25892	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	960719	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	942685	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	60713	usd
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	61326	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	151200	usd
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	300600	usd
CY2022Q2	us-gaap	Liabilities Liabilities	1172632	usd
CY2021Q2	us-gaap	Liabilities Liabilities	1304611	usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73047868	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73047868	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75787868	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75787868	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	75788	usd
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	73048	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62918787	usd
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62805404	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60848452	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61280339	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2146123	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1598113	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3318755	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2902724	usd
CY2022	us-gaap	Revenues Revenues	6495530	usd
CY2021	us-gaap	Revenues Revenues	4863412	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	4740931	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	3579227	usd
CY2022	us-gaap	Gross Profit GrossProfit	1754599	usd
CY2021	us-gaap	Gross Profit GrossProfit	1284185	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	101817	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	102265	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	281440	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	224686	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	963890	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	860693	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1347147	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	1187644	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	407452	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	96541	usd
CY2022	us-gaap	Interest Expense InterestExpense	65	usd
CY2021	us-gaap	Interest Expense InterestExpense	0	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1390	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	1710	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	149570	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-395	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-26183	usd
CY2022	us-gaap	Other Income OtherIncome	23505	usd
CY2021	us-gaap	Other Income OtherIncome	36698	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	24435	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	161795	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	431887	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	258336	usd
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	0	usd
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	0	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	431887	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	258336	usd
CY2022	amty	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	0.01
CY2021	amty	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	0
CY2022	amty	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	74042279	shares
CY2021	amty	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	70918758	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	1250971	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	88806	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	258336	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1598113	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	116123	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	431887	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2146123	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	431887	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	258336	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	230162	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	210696	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	116123	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	88806	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	149570	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-395	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-26183	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-42670	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	435674	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	25061	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	39220	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	217865	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	45176	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-66187	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	82155	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	82421	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	13700	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-147600	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-145799	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	446945	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-135563	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	154617	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3675	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2750	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10786	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-157367	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14461	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	50000	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	50000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	613	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	540	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-613	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-540	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	288965	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-150564	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	516192	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	666756	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	805157	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	516192	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	65	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	0	usd
CY2021	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	131131	usd
CY2022	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	36327	usd
CY2021	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	31203	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Estimates</i></p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management routinely makes judgments on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Concentrations of Risk</i></p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company places its cash accounts with high credit quality financial institutions and generally limits the amount of credit exposure to the amount in excess of the FDIC insurance coverage limit of $250,000 for interest bearing accounts. As of June 30, 2022, and 2021, the Company has a series of accounts at one bank that collectively exceed this amount at each year end. The Company has not experienced losses in such accounts and believes it is not exposed to any significant credit risk to cash.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Credit losses, if any, have been provided for in the financial statements and are based on management’s expectations. The Company’s accounts receivables are subject to potential concentrations of credit risk. The Company does not believe that it is subject to any unusual risks or significant risks in the normal course of its business.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">We have one customer who accounted for 27% of our sales for the year ended June 30, 2022. This same customer accounted for 28% of our sales for the year ended June 30, 2021.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">While the Company conducts most of its business in the United States, revenue related to foreign sales was $2,128,282 and $1,656,937 as of June 30, 2022, and 2021. Foreign sales for the year ended June 30, 2022 was 33% of total sales; for the year ended June 302, 2021 this was 34% of total net revenues.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022	us-gaap	Depreciation Depreciation	46525	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	769277	usd
CY2021Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	416709	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	403517	usd
CY2021Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	525565	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	132307	usd
CY2021Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	119652	usd
CY2022Q2	amty	Invenory Current And Noncurrent Net InvenoryCurrentAndNoncurrentNet	1040487	usd
CY2021Q2	amty	Invenory Current And Noncurrent Net InvenoryCurrentAndNoncurrentNet	822622	usd
CY2021	us-gaap	Depreciation Depreciation	47969	usd
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	487633	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	429419	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	58214	usd
CY2021Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	487633	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	411656	usd
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	75977	usd
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17763	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16927	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12738	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	16337	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7464	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5270	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4974	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	11431	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	116123	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	88806	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	6900	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	17300	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2900	usd
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1030000	shares
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7804200	usd
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8334200	usd
CY2022Q2	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	3900	usd
CY2021Q2	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	4000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	27800	usd
CY2021Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	25100	usd
CY2022Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	216300	usd
CY2021Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	209800	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-9800	usd
CY2021Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-8000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	22700	usd
CY2021Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	5400	usd
CY2022Q2	amty	Deferred Tax Liabilities Property Plant And Equipment1 DeferredTaxLiabilitiesPropertyPlantAndEquipment1	56500	usd
CY2021Q2	amty	Deferred Tax Liabilities Property Plant And Equipment1 DeferredTaxLiabilitiesPropertyPlantAndEquipment1	19700	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8028200	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8566800	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-90700	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-54300	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation IncomeTaxReconciliationNondeductibleExpenseDepreciation	-34300	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation IncomeTaxReconciliationNondeductibleExpenseDepreciation	-5900	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	24400	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	18600	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	2700	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	1400	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	600	usd
CY2022	us-gaap	Income Tax Reconciliation Disposition Of Assets IncomeTaxReconciliationDispositionOfAssets	1800	usd
CY2021	us-gaap	Income Tax Reconciliation Disposition Of Assets IncomeTaxReconciliationDispositionOfAssets	3700	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	100	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	300	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-104100	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-81400	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	37163000	usd
CY2022Q2	us-gaap	Deferred Revenue DeferredRevenue	108313	usd
CY2021Q2	us-gaap	Deferred Revenue DeferredRevenue	25892	usd
CY2022	us-gaap	Product Warranty Expense ProductWarrantyExpense	0	usd
CY2021	us-gaap	Product Warranty Expense ProductWarrantyExpense	7800	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	2116	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	2177	usd
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	149570	usd
CY2020Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P2Y
CY2020Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2020Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	50000	usd
CY2022	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	50000	usd
CY2022Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	100000	usd
CY2022	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0575	pure
CY2022Q2	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.045	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1030000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.12
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1840000	shares
CY2022Q2	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	300600	usd
CY2021Q2	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	448200	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	289604	usd
CY2021Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	286854	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	204838	usd
CY2021Q2	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	190984	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	385366	usd
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	544070	usd
CY2022Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	49200	sqft
CY2022Q2	us-gaap	Area Of Land AreaOfLand	4.15	acre
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	448200	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	147600	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	145800	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	30000	shares
CY2021	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	245000	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	500000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	vest monthly (in equal installments) February 2022 – November 2022
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.049
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1030000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.12
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2870000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.12
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.12
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1030000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.12
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1030000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.12
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022	dei	Security Exchange Name SecurityExchangeName	NONE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000945828

Files In Submission

Name	View Source	Status
0001185185-22-001115-index-headers.html	Edgar Link	pending
0001185185-22-001115-index.html	Edgar Link	pending
0001185185-22-001115.txt	Edgar Link	pending
0001185185-22-001115-xbrl.zip	Edgar Link	pending
amerityre20220630_10k.htm	Edgar Link	pending
amerityre20220630_10kimg001.jpg	Edgar Link	pending
amty-20220630.xsd	Edgar Link	pending
ex_423893.htm	Edgar Link	pending
ex_423894.htm	Edgar Link	pending
ex_423895.htm	Edgar Link	pending
ex_423896.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
amty-20220630_pre.xml	Edgar Link	unprocessable
amty-20220630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
amty-20220630_def.xml	Edgar Link	unprocessable
amty-20220630_lab.xml	Edgar Link	unprocessable
amerityre20220630_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMTY
AMERITYRE CORP Stock $amty

2022 Q3 Form 10-K Financial Statement

#000118518522001115 Filed on September 19, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMTY AMERITYRE CORP Stock $amty

2022 Q3 Form 10-K Financial Statement

#000118518522001115 Filed on September 19, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMTY
AMERITYRE CORP Stock $amty